SAB Biotherapeutics Inc. (SABS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.56
0.01 (0.28%)
At close: Jan 15, 2025, 3:01 PM
SAB Biotherapeutics Inc. Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for SABS stock have an median target of 9.5, with a low estimate of 6 and a high estimate of 12. The median target predicts an increase of 166.85% from the current stock price of 3.56.
Analyst Consensus: Buy
AI Analyst Report
Chardan Capital has reaffirmed its Buy rating for ... Unlock content with Pro Subscription
Updated Nov 07, 2024
Financial Forecast this Year
Revenue This Year
1.32M
from 2.24M
Increased by -40.9%
Revenue Next Year
800.00K
from 1.32M
Increased by -39.5%
EPS This Year
-3.68
from -7.64
Increased by 51.8%
EPS Next Year
-3.09
from -3.68
Increased by 16.0%